Genmab — Januar 2019
-
Genmab indgår forlig med tyske Morphosys
Aftalen betyder, at Morphosys ikke anker sit nederlag i en patenttvist med Genmab og partneren Janssen.
(medwatch.dk)
-
Winkel var lidt mere skeptisk på CC Q3: ... about the November 27 summary judgment. We cannot say too much about the process, but technically, the case could be over, then we get a positive judgment there. However, we anticipate it will go to the jury trial early next year in February.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind